Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ED-FOL is a marketed multi-ingredient nutraceutical product developed and manufactured by Zaiva Lifesciences, an Indian pharmaceutical company. It is formulated as an oral tablet containing a combination of L-arginine (500 mg), proanthocyanidin (75 mg), selenium (65 mcg), ginkgo biloba (40 mg), ginseng (42.5 mg), green tea extract (10 mg), garlic powder (2 mg), and lycopene (2500 mcg). This product is designed to support cardiovascular health, provide antioxidant protection, and potentially aid male reproductive health. L-arginine serves as a precursor for nitric oxide, which promotes vasodilation and improved blood flow, while the botanical extracts and selenium offer synergistic antioxidant effects to combat oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ED-FOL.